Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04768920 · ClinicalTrials.gov registry record · NA
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
A NA study of Substance Use Disorders and Substance Use, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04768920: Active NA study of Substance Use Disorders and Substance Use, sponsored by University of Michigan.
NCT04768920 is a NA study of Substance Use Disorders and Substance Use that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 50 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04768920, a NA study of Substance Use Disorders and Substance Use, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot intervention study is to iteratively refine motivational interviewing and psychosocial intervention programs delivered via telehealth (Teletx) to help improve substance use and other related outcomes in SUD patients who are not receiving SUD care. We will examine feasibility and acceptability of these pilot psychosocial programs in a total of n=50 participants. The goal is to refine the programs to improve acceptability and feasibility and collect preliminary data for a future fully powered randomized controlled trial (RCT) in the future. In addition to study sessions, participants that are enrolled in the study will complete surveys prior to, during, and after treatment.
Primary Outcome
Percent (%) of participants engaging in the intervention
Conditions Studied
Interventions
- BEHAVIORAL MI-CBT Teletx
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT04768920 still lists
NCT04768920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which MI-CBT Teletx is the first listed.
NCT04768920 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04768920 about?
NCT04768920 is a clinical study titled "Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)". The objective of this pilot intervention study is to iteratively refine motivational interviewing and psychosocial intervention programs delivered via telehealth (Teletx) to help improve substance use and other related outcomes in SUD patients who are not receiving SUD care. We will examine feasibil...
What is the current status of trial NCT04768920?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-11. Estimated completion is 2026-02-28.
What conditions does trial NCT04768920 study?
This clinical trial studies the following conditions: Substance Use Disorders, Substance Use, Substance Dependence.
What interventions are being tested in trial NCT04768920?
The interventions under investigation include: MI-CBT Teletx (BEHAVIORAL).
Who is sponsoring clinical trial NCT04768920?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04768920 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04768920's enrollment target sits among peer trials
50 69th of 93 higher than 21 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI